STERIS (STE) Q4 FY26 earnings call: guidance and Q&A

Can you walk through the moving pieces for the anticipated 50 bps EBIT margin expansion in FY27, including inflation, energy prices, tariffs, and underlying performance?

Management expects to maximize the 50 bps expansion through operational improvements and continued sell-through of higher-margin consumables. Tariffs are expected to be favorable in FY27, offsetting volume increases. A $20 million bonus tailwind is expected from modeling 100% achievement in FY27 versus overachievement in FY26. Freight is the largest challenge, but most costs are recoverable, and raw materials impacted by oil are less than 20% of COGS.

“The good news is in terms of tariffs, the recent changes are favorable to us. and served to offset the volume increase for next year. So in an odd twist, tariffs are an okay thing for us looking at '27.”

asked by Brett Fishbin · answered by Karen Burton

How should we think about the overall phasing for organic growth in FY27, particularly for AST services given difficult comps?

The slower start in the first half of FY27 is more specific to AST comps, which saw double-digit growth in the first two quarters of FY26, followed by a slowdown in Q3 (inventory flow back) and Q4 (snowstorms, losing 150-200 bps of growth). Management expects significant improvement in Q3 and easier comps in Q4.

“Yes, really more specific to the AST comps. We started the year last year, first couple of quarters in double-digit growth in that business. and then saw a bit of a slowdown in Q3 where we saw some inventory flow back from our customers.”

asked by Brett Fishbin · answered by Daniel Carestio

What is your expectation for the USMCA renegotiation this year, and what have you assumed in your guidance?

STERIS has not included any assumption for USMCA in its guidance. The company assumes it will likely move into an annual continual review phase in the short term, as all three governments have emphasized continuity and avoiding disruption.

“We're assuming stagnant and that it will likely move into annual continual review phase at least in the short term.”

asked by Michael Matson · answered by Karen Burton

Should the $1 billion buyback authorization be read as an indication of not pursuing sizable M&A or reflecting valuation issues in the sector?

Management stated that M&A is erratic, occurring when opportunities arise. The tuck-in deals were called out due to their material impact on Healthcare's FY27 performance (close to 100 bps). The buyback is important for the company's health, addressing prior withholding tax issues that had held back consistent buybacks.

“I would say no. I mean, our M&A is erratic at times because it's when opportunities present themselves that have been working on for a long period of time.”

asked by David Turkaly · answered by Daniel Carestio

Can you speak to what you saw in AST as the quarter progressed, particularly on the volume side, given med tech customers continuing to manage inventory levels carefully?

Organic volume in AST was less than anticipated in the last two quarters. Q4 was impacted by snowstorms, causing plant and customer shutdowns. Management observed an inventory reduction across the broader med tech customer segment, despite consistent mid-single-digit procedure growth and strong top-line sales from large med tech companies, indicating an inventory pullback.

“But what we have seen and maybe it's post-tariff confidence in supply chains, maybe it's whatever, but we've seen some inventory reduction across the broader customer segment, right, in terms of med tech and what we know is this.”

asked by Steven Etoch · answered by Daniel Carestio

What are the motivations for consolidating three facilities into one new sterility assurance plant, and what operating efficiencies are expected?

STERIS is consolidating three facilities (two local) due to the high-growth, high-margin nature of the sterility assurance business and its success in gaining market share. The new plant is capacity-driven and will be a nearly fully automated manufacturing center of excellence, providing some cost benefits but primarily supporting long-term growth.

“First off, we've got 3 different facilities, 2 of them happen to be here locally and it just makes sense to consolidate. But the real driving issue here is this has been a really high-growth and high-margin business for us at STERIS and one that we've been really successful in picking up share in our Healthcare organization, in particular, as most every system now is at least dual source to STERIS.”

asked by David Windley · answered by Daniel Carestio

Can you clarify the total tariff headwind in FY26, what's embedded in FY27, and if FY27 includes refunds? Also, explain the $20 million bonus tailwind.

FY26 incremental tariffs were $46 million, leading to a total tariff spend of $60 million-$65 million modeled for FY27. No refunds are included in FY27 guidance. The $20 million bonus tailwind results from FY26 overachievement, while FY27 guidance models 100% achievement.

“In terms of tariffs, our incremental tariffs in '26 was $46 million, which puts us at a total tariff spend between $60 million and $65 million, and that's what we're modeling for '27. We are not including any refunds in our '27 guidance.”

asked by Michael Polark · answered by Karen Burton

What is STERIS seeing regarding chip and critical component supply, and what's assumed for COGS inflation in the guide?

STERIS is a vastly different and more resilient organization than a few years ago, with significant investments in supply chain resources and mitigation of single-source supply. They strategically hold excess inventory for critical parts. Routine labor inflation is expected. Raw materials (metals, plastics, electronics, chemicals) are less than 20% of COGS, with some upward pressure from oil, which also impacts freight and fuel costs. Chips are not a significant cost component overall.

“What I would say is we're a vastly different organization today than we were a few years ago when we went through the Golden strew diaries or whatever we want to call it, it was a miserable time for all of us.”

asked by Jason Bednar · answered by Daniel Carestio